Strong Momentum Drives New Peak
On 12 Dec 2025, Everest Organics opened with a gap up of 2.12%, signalling strong buying interest from the outset. The stock touched an intraday high of Rs.499, representing a 4% rise within the trading session. This movement contributed to a day’s gain of 2.33%, notably outperforming the Sensex, which recorded a 0.44% increase on the same day. The stock’s outperformance extended beyond the daily timeframe, with a one-week return of 12.32% compared to the Sensex’s decline of 0.61%.
Everest Organics has demonstrated consistent upward momentum, registering gains for six consecutive trading days. During this period, the stock delivered a cumulative return of 19.26%, underscoring sustained investor confidence and positive market dynamics within the Pharmaceuticals & Biotechnology sector.
Technical Indicators Reflect Strength
The stock is trading above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning suggests a broad-based strength across short, medium, and long-term horizons. Such alignment of moving averages often indicates a favourable trend and can be a sign of underlying market support.
Comparative Performance Over Various Timeframes
Everest Organics’ performance over multiple timeframes reveals a pattern of significant appreciation relative to the broader market. Over the past month, the stock recorded a 23.13% return, while the Sensex posted a modest 0.86% gain. The three-month period saw Everest Organics rise by 16.57%, outpacing the Sensex’s 4.01% increase.
Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!
- - Clear entry/exit targets
- - Target price revealed
- - Detailed report available
Looking at longer-term performance, Everest Organics has delivered a remarkable 104.58% return over the past year, significantly outstripping the Sensex’s 4.80% gain. Year-to-date figures also highlight a 63.10% return for the stock, compared with the Sensex’s 9.03%. Over three years, the stock’s appreciation stands at 286.31%, dwarfing the Sensex’s 37.12% rise during the same period.
Sector and Market Capitalisation Context
Operating within the Pharmaceuticals & Biotechnology sector, Everest Organics’ market capitalisation grade is rated at 4, reflecting its standing among mid-to-large cap companies in the industry. The stock’s recent performance has outpaced the sector by 2.31% on the day of the new high, reinforcing its relative strength within its peer group.
Over five years, Everest Organics has recorded an 86.87% return, closely tracking the Sensex’s 84.80% gain. This suggests that while the stock has shown exceptional shorter-term growth, its longer-term trajectory aligns more closely with broader market trends. The absence of a 10-year return figure for Everest Organics contrasts with the Sensex’s 240.16% gain over the same period, indicating the company’s more recent emergence or listing in the market.
Market Capitalisation and Trading Activity
Everest Organics’ market capitalisation reflects its position as a significant player in the Pharmaceuticals & Biotechnology sector. The stock’s trading activity, including its consistent gains and ability to maintain levels above key moving averages, points to a well-supported price level. This foundation has enabled the stock to reach its all-time high of Rs.499, a milestone that marks a new chapter in its market presence.
Holding Everest Organics from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Everest Organics’ Market Journey
Everest Organics’ ascent to an all-time high price of Rs.499 is the culmination of sustained gains across multiple timeframes and consistent outperformance relative to the Sensex and its sector. The stock’s ability to maintain levels above all major moving averages and its steady upward momentum over the past six days highlight a strong technical foundation.
The company’s performance metrics over one month, three months, one year, and three years illustrate a pattern of robust growth, with returns that have frequently outpaced the broader market. While the five-year returns align more closely with the Sensex, the recent acceleration in price underscores a period of notable market recognition.
Everest Organics’ position within the Pharmaceuticals & Biotechnology sector, combined with its market capitalisation grade, situates it as a significant entity within its industry. The stock’s recent price action and milestone achievement reflect a phase of heightened market activity and valuation.
As the stock now stands at its highest-ever level, it represents a key reference point for market participants and analysts tracking the Pharmaceuticals & Biotechnology sector’s evolving landscape.
Only for Rs. 14,999 - Get Access to 2 Years + 6 Months of All Premium Features on MarketsMojo. As low as ₹500/month! Claim 83% OFF →
